1. Home
  2. UTZ vs GYRE Comparison

UTZ vs GYRE Comparison

Compare UTZ & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utz Brands Inc

UTZ

Utz Brands Inc

HOLD

Current Price

$7.36

Market Cap

681.8M

ML Signal

HOLD

Logo Gyre Therapeutics Inc.

GYRE

Gyre Therapeutics Inc.

HOLD

Current Price

$7.31

Market Cap

679.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTZ
GYRE
Founded
2018
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
681.8M
679.4M
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
UTZ
GYRE
Price
$7.36
$7.31
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$11.93
$17.00
AVG Volume (30 Days)
1.7M
52.0K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
3.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,438,800,000.00
$275,000.00
Revenue This Year
$5.16
$19.88
Revenue Next Year
$1.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.09
N/A
52 Week Low
$7.12
$6.58
52 Week High
$14.67
$11.67

Technical Indicators

Market Signals
Indicator
UTZ
GYRE
Relative Strength Index (RSI) 42.67 46.37
Support Level $7.27 $6.90
Resistance Level $8.01 $8.28
Average True Range (ATR) 0.35 0.37
MACD -0.03 -0.06
Stochastic Oscillator 10.47 26.76

Price Performance

Historical Comparison
UTZ
GYRE

About UTZ Utz Brands Inc

Utz Brands Inc is a manufacturer of branded salty snacks based in the United States. It produces various salty snack foods, including potato chips, tortilla chips, pretzels, cheese snacks, party mixes, pork skins, ready-to-eat popcorn, and other snacks, which include salsa and dips. These products are offered through its flagship brands like Utz, On The Border, Zapp's, and Boulder Canyon, along with other brands, including Golden Flake, Miguelito's, Hawaiian, Bachman, Tim's Cascade, Dirty Potato Chips, TGI Fridays, and Vitner's. The company's products are packaged in a variety of different sizes and configurations, ranging from individual packages to shareable bulk containers. It also sells certain third-party branded products through its distribution network.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Share on Social Networks: